small molecule

ALSUMA

SUMATRIPTAN SUCCINATE

Loss of exclusivityAugust 2027latest FDA-listed patent expiry

CompanyMERIDIAN MEDICAL TECHNOLOGIES INC SUB KING PHARMACEUTICALS INC

Drug detail

Brand name	ALSUMA
Active ingredient	SUMATRIPTAN SUCCINATE
Strength	EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)
Dosage form	INJECTABLE
Route	SUBCUTANEOUS
Modality	Small molecule
FDA approval	June 2010
Marketing status	DISCN

Listed patents

Patent	Expires	Type
7811254	August 2027	product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.